243 related articles for article (PubMed ID: 21418284)
21. Melanoma in situ in Puerto Rico: clinical characteristics and detection patterns.
Muñoz C; Vázquez-Botet M
P R Health Sci J; 2004 Sep; 23(3):179-82. PubMed ID: 15631171
[TBL] [Abstract][Full Text] [Related]
22. Serial screening for melanoma: measures and strategies that have consistently achieved early detection and cure.
Shore RN; Shore P; Monahan NM; Sundeen J
J Drugs Dermatol; 2011 Mar; 10(3):244-52. PubMed ID: 21369639
[TBL] [Abstract][Full Text] [Related]
23. Behavioral determinants of successful early melanoma detection: role of self and physician skin examination.
Swetter SM; Pollitt RA; Johnson TM; Brooks DR; Geller AC
Cancer; 2012 Aug; 118(15):3725-34. PubMed ID: 22179848
[TBL] [Abstract][Full Text] [Related]
24. [Investigation of malignant melanoma in an "open house" setting].
Poulsen AG; Larsen FG; Weismann K; Petersen CS; Ravnborg LR; Heidenheim M; Lauritzen TE; Held E; Osterlind AL
Ugeskr Laeger; 1999 Mar; 161(12):1758-61. PubMed ID: 10210976
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of factors associated with skin self-examination.
Oliveria SA; Christos PJ; Halpern AC; Fine JA; Barnhill RL; Berwick M
Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):971-8. PubMed ID: 10566551
[TBL] [Abstract][Full Text] [Related]
26. Thick melanoma: the problem continues.
Tejera-Vaquerizo A; Mendiola-Fernández M; Fernández-Orland A; Herrera-Ceballos E
J Eur Acad Dermatol Venereol; 2008 May; 22(5):575-9. PubMed ID: 18081751
[TBL] [Abstract][Full Text] [Related]
27. Melanoma in middle-aged and older men: a multi-institutional survey study of factors related to tumor thickness.
Swetter SM; Johnson TM; Miller DR; Layton CJ; Brooks KR; Geller AC
Arch Dermatol; 2009 Apr; 145(4):397-404. PubMed ID: 19380661
[TBL] [Abstract][Full Text] [Related]
28. Melanomas detected with the aid of total cutaneous photography.
Feit NE; Dusza SW; Marghoob AA
Br J Dermatol; 2004 Apr; 150(4):706-14. PubMed ID: 15099367
[TBL] [Abstract][Full Text] [Related]
29. Melanoma of the ear: prognostic factors and surgical strategies.
Jahn V; Breuninger H; Garbe C; Moehrle M
Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
[TBL] [Abstract][Full Text] [Related]
30. What motivates men age > or =50 years to participate in a screening program for melanoma?
Janda M; Youl PH; Lowe JB; Baade PD; Elwood M; Ring IT; Aitken JF
Cancer; 2006 Aug; 107(4):815-23. PubMed ID: 16832794
[TBL] [Abstract][Full Text] [Related]
31. [Tumour regression is not predictive for higher risk of sentinel node involvement in thin melanomas (Breslow thickness < or = 1 mm)].
Kramkimel N; Maubec E; Boitier F; Cavalcanti A; Beldi M; Mamelle G; Kolb F; Duvillard P; Avril MF
Ann Dermatol Venereol; 2010 Apr; 137(4):276-80. PubMed ID: 20417360
[TBL] [Abstract][Full Text] [Related]
32. [Stage I malignant melanoma of the skin. Prognostic value of thickness and level (author's transl)].
Palangié A; Lassau F; Moreau T; Noury-Duperrat G; Cottenot F
Nouv Presse Med; 1981 Jun; 10(28):2337-41. PubMed ID: 7267338
[TBL] [Abstract][Full Text] [Related]
33. Time trends in features of cutaneous melanoma at diagnosis: central-south Italy, 1962-1991.
Cavalieri R; Macchini V; Mostaccioli S; Sonego G; Ferranti G; Corona R; Fucci M; Marzolini F; Rosmini F; Pasquini P
Ann Ist Super Sanita; 1993; 29(3):469-72. PubMed ID: 8172468
[TBL] [Abstract][Full Text] [Related]
34. Strategies for improving melanoma education and screening for men age >or= 50 years: findings from the American Academy of Dermatological National Skin Cancer Sreening Program.
Geller AC; Sober AJ; Zhang Z; Brooks DR; Miller DR; Halpern A; Gilchrest BA
Cancer; 2002 Oct; 95(7):1554-61. PubMed ID: 12237925
[TBL] [Abstract][Full Text] [Related]
35. Older age and second skin cancer as prognostic factors in localized malignant melanomas.
Brenner B; Borok S; Rakowsky E; Fenig E; Gutman H; Sulkes J; Sulkes A; Schachter J
Oncol Rep; 2003; 10(6):2051-7. PubMed ID: 14534742
[TBL] [Abstract][Full Text] [Related]
36. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
37. A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma.
McKenna DB; Marioni JC; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Sep; 151(3):636-44. PubMed ID: 15377351
[TBL] [Abstract][Full Text] [Related]
38. Presentation and detection of invasive melanoma in a high-risk population.
McPherson M; Elwood M; English DR; Baade PD; Youl PH; Aitken JF
J Am Acad Dermatol; 2006 May; 54(5):783-92. PubMed ID: 16635658
[TBL] [Abstract][Full Text] [Related]
39. Management of malignant melanoma.
Kroon BB; Nieweg OE
Ann Chir Gynaecol; 2000; 89(3):242-50. PubMed ID: 11079795
[TBL] [Abstract][Full Text] [Related]
40. Increased melanoma risk in Parkinson disease: a prospective clinicopathological study.
Bertoni JM; Arlette JP; Fernandez HH; Fitzer-Attas C; Frei K; Hassan MN; Isaacson SH; Lew MF; Molho E; Ondo WG; Phillips TJ; Singer C; Sutton JP; Wolf JE;
Arch Neurol; 2010 Mar; 67(3):347-52. PubMed ID: 20212233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
